CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.
Cell Biol Toxicol
; 39(4): 1549-1560, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-35913601
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Gemcitabine
Limits:
Humans
Language:
En
Journal:
Cell Biol Toxicol
Journal subject:
TOXICOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland